Plas DR - Search Results

1

Tubers and tumors: rapamycin therapy for benign and malignant tumors.

Plas DR, Thomas G. Plas DR, et al. Curr Opin Cell Biol. 2009 Apr;21(2):230-6. doi: 10.1016/j.ceb.2008.12.013. Epub 2009 Feb 23. Curr Opin Cell Biol. 2009. PMID: 19237273 Review.

2

FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1.

Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR. Khatri S, et al. Among authors: plas dr. J Biol Chem. 2010 May 21;285(21):15960-5. doi: 10.1074/jbc.M110.121871. Epub 2010 Apr 6. J Biol Chem. 2010. PMID: 20371605 Free PMC article.

3

Identification of Akt-selective cytotoxic compounds that enhance cytotoxic responses to rapamycin.

Barger JF, Gallo CA, Torni KA, Merk L, Seibel WL, Nelson S, Plas DR. Barger JF, et al. Among authors: plas dr. Cancer Biol Ther. 2010 Dec 15;10(12):1256-61. doi: 10.4161/cbt.10.12.13442. Epub 2010 Dec 15. Cancer Biol Ther. 2010. PMID: 20935504 Free article.

4

Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 Inhibition.

Yoon SO, Shin S, Karreth FA, Buel GR, Jedrychowski MP, Plas DR, Dedhar S, Gygi SP, Roux PP, Dephoure N, Blenis J. Yoon SO, et al. Among authors: plas dr. Mol Cell. 2017 Aug 3;67(3):512-527.e4. doi: 10.1016/j.molcel.2017.06.033. Epub 2017 Jul 27. Mol Cell. 2017. PMID: 28757207 Free PMC article.

5

Selective MAP1LC3C (LC3C) autophagy requires noncanonical regulators and the C-terminal peptide.

Bischoff ME, Zang Y, Chu J, Price AD, Ehmer B, Talbot NJ, Newbold MJ, Paul A, Guan JL, Plas DR, Meller J, Czyzyk-Krzeska MF. Bischoff ME, et al. Among authors: plas dr. J Cell Biol. 2021 Jul 5;220(7):e202004182. doi: 10.1083/jcb.202004182. Epub 2021 May 14. J Cell Biol. 2021. PMID: 33988680 Free PMC article.

6

Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis.

Barger JF, Plas DR. Barger JF, et al. Among authors: plas dr. Endocr Relat Cancer. 2010 Sep 23;17(4):R287-304. doi: 10.1677/ERC-10-0106. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20699334 Review.

7

Akt-dependent glucose metabolism promotes Mcl-1 synthesis to maintain cell survival and resistance to Bcl-2 inhibition.

Coloff JL, Macintyre AN, Nichols AG, Liu T, Gallo CA, Plas DR, Rathmell JC. Coloff JL, et al. Among authors: plas dr. Cancer Res. 2011 Aug 1;71(15):5204-13. doi: 10.1158/0008-5472.CAN-10-4531. Epub 2011 Jun 13. Cancer Res. 2011. PMID: 21670080 Free PMC article.

8

S6K1 determines the metabolic requirements for BCR-ABL survival.

Barger JF, Gallo CA, Tandon P, Liu H, Sullivan A, Grimes HL, Plas DR. Barger JF, et al. Among authors: plas dr. Oncogene. 2013 Jan 24;32(4):453-61. doi: 10.1038/onc.2012.70. Epub 2012 Mar 5. Oncogene. 2013. PMID: 22391570 Free PMC article.

9

VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma.

Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J, Czyzyk-Krzeska MF. Mikhaylova O, et al. Among authors: plas dr. Cancer Cell. 2012 Apr 17;21(4):532-46. doi: 10.1016/j.ccr.2012.02.019. Cancer Cell. 2012. PMID: 22516261 Free PMC article.

10

ERK2 Mediates Metabolic Stress Response to Regulate Cell Fate.

Shin S, Buel GR, Wolgamott L, Plas DR, Asara JM, Blenis J, Yoon SO. Shin S, et al. Among authors: plas dr. Mol Cell. 2015 Aug 6;59(3):382-98. doi: 10.1016/j.molcel.2015.06.020. Epub 2015 Jul 16. Mol Cell. 2015. PMID: 26190261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters